Table 2.
Compounds Name | Chemical Shift Peaks (ppm) | Identification Level * | Associated Medicinal Properties | References |
---|---|---|---|---|
Niazirin | δ 7.16, 7.26 | Level 2 | Anticancer activities | [4,6] |
Wogonin | δ 6.32, 7.09, 7.59 | Level 2 | Anti-inflammatory | [33] |
Esculetin | δ 7.42,7.55 | Level 2 | Antioxidant, anti-inflammatory | [34] |
Chlorogenic acid | δ 6.410, 7.05, 7.15, 7.64 | Level 3 | Anti-inflammatory, anti-oxidants, antispasmodic, anti-cancer, anti-obesity | [35,36,37,38,39] |
Ferulic acid | δ 6.38, 6.86, 7.05, 7.33 | Level 2 | Anti-oxidants, anti-microbial, anti-inflammatory, anti-diabetic | [28,40,41,42,43,44] |
Vanillic acid | δ 6.94, 7.55, 7.65 | Level 2 | Anti-inflammatory, anti-oxidants, anti-cancer, anti-sickling, anti-microbial | [36,45,46,47] |
Gamma-aminobutyric Acid (GABA) | δ 1.9, 2.3, 3.0 | Level 3 | Anti-epileptic, anti-anxiety | [48,49] |
* Level 2 = putatively annotated compounds without chemical reference standards, but based upon physicochemical properties and/or spectral similarity with public/commercial spectral libraries; Level 3 = spiking with commercial chemicals to confirm their annotation [50].